Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion

Leukemia. 2012 Jun;26(6):1414-6. doi: 10.1038/leu.2011.348. Epub 2011 Dec 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • DNA, Neoplasm / genetics
  • Feasibility Studies
  • Humans
  • Ikaros Transcription Factor / genetics*
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / genetics
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / genetics*
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / physiopathology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Predictive Value of Tests
  • Risk Assessment
  • Sequence Deletion*

Substances

  • DNA, Neoplasm
  • IKZF1 protein, human
  • Ikaros Transcription Factor